UK phase 1 - ADZ5363 - New cancer drug to be tested by patients - Business News - Healthcare Digital

"Medication that prevents the enzyme, Protein Kinase B (PKB), has the potential to treat breast cancer, prostate cancer, ovarian cancer, pancreatic cancer and gastric cancers.

The Royal Marsden NHS Foundation Trust and the Christie Hospital NHS Trust in the UK are going to be involved in testing the drug, along with a hospital in the Netherlands.

Scientists and doctors are looking for patients with advanced solid tumours to test the drug, in order to determine the safety, tolerability and initial anti-cancer activity of ADZ5363....."